Genetics & Longevity

Genetics and Preventive Medicine

Using genetic insight to prioritize screening — not to predict fate.

Monika Mikulicz-Pasler·MD, PhD11 min read
Editorial portrait representing personalized genetic longevity care

The human genome contains approximately three billion base pairs, yet only a fraction of variants have established clinical significance. Longevity-focused genetic assessment prioritizes variants with evidence-based management guidelines — Lynch syndrome, familial hypercholesterolemia, BRCA mutations, and pharmacogenomic markers that affect drug metabolism.

About the author

Monika Mikulicz-Pasler

Medical Director, KCM Clinic · Specialist in Cardiology & Internal Medicine·MD, PhD

Dr. Mikulicz-Pasler leads physician-guided longevity care at KCM Clinic, with deep expertise in cardiology, internal medicine, and preventive health strategy. A member of the Polish Society of Longevity Medicine, she focuses on early interpretation of cardiovascular and systemic risk — translating advanced diagnostics into clear, personalized pathways for healthier aging.